In October 2015, results were released from two animal studies investigating the transdermal use of cannabidiol (CBD) for the treatment of each of the diseases mentioned. In both cases, the results were very encouraging.
CBD hemp oil and multiple sclerosis
The results were published by two American scientists in the European Journal of Pain Research. The authors of the study studied in a mouse model of arthritis effect of the CBD gel (daily dose 0.6 / 3.1 / 6.2 or 62.3 mg) for inflammatory processes. In particular, the arthritis model was treated with CBD gel for 4 days.
According to the conclusion,a transdermal gel containing CBD significantly reduced swelling, reduced pain in the extremities and prevented infiltration by immune cells, and also reduced inflammation in the synovial membranes in a dose-dependent manner”. The most effective dosage was found to be 6.2 and 62mg CBD daily, with no effect on pattern recognition capabilities, suggesting that CBD use has only a limited effect on higher brain functions.
CBD hemp oil and arthritis
The conclusions of the second study were presented in the Tehran Medical University journal “DARU: Journal of Faculty and Pharmacy”. They are as follows: topical cream with 1% purified CBD (crystalline powder containing at least 98% CBD) helps with a single daily application, effectively fights inflammation in the brain. The cream was tested on rodents with experimental autoimmune encephalomyelitis, which is a model of multiple sclerosis in mice.
In conclusion, the researchers “surprisingly” found that a 1% CBD cream “has a neuroprotective effect, improves the condition of paralysis of the hind limbs, alleviates the course of diseases of the spine, and also reduces the undesirable formation of lymphocytes in the spleen and other inflammatory cytokines”.
